Abstract
Mesenchymal stem cells (MSCs) represent a promising alternative form of cell-based therapy for cartilage injury.
However, the capacity of MSCs for chondrogenesis has not been fully explored. In particular, there is presently a lack of studies comparing the effectiveness of MSCs to conventional autologous chondrocyte (autoC) treatment for regeneration of full-thickness cartilage defects in vivo.
Original language | English |
---|---|
Pages (from-to) | 83 - 90 |
Number of pages | 8 |
Journal | The American Journal of Sports Medicine |
Volume | 4 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2012 |